Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Conditions

• Leukemia, Myelomonocytic, Chronic

Interventions

• DRUG: Pacritinib
• DRUG: Hydroxyurea

Sponsor

Theradex

Collaborators

• [object Object]
• [object Object]
• [object Object]